HBV | Pedestal Health

2

Total Publications

1

Abstract/Manuscript

1

Poster Presentation

2021 · Abstract/Manuscript · Abstract/Manuscript

Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBV.

2019 · Poster Presentation · Care · Hepatology

Effectiveness of Tenofovir Alafenamide in Patients with Chronic Hepatitis B Treated in Usual Clinical Practice: Results from the TARGET-HBV Observational Cohort Study.

News — Target RWE HBV Research on Antiviral Treatments, Characteristics, and Clinical O | Grid

Target RWE HBV Research on Antiviral Treatments, Characteristics, and Clinical Outcomes Published in Digestive Diseases and Sciences

News — TARGET PharmaSolutions to Advance Research in NASH and Hepatitis B Through New C | Grid

TARGET PharmaSolutions to Advance Research in NASH and Hepatitis B Through New Collaboration with Gilead Sciences

News — TARGET PharmaSolutions Initiates a New Community, TARGET-HBV, to Advance the Und | Grid

TARGET PharmaSolutions Initiates a New Community, TARGET-HBV, to Advance the Understanding of Hepatitis B